Description
Zolpidem
Zolpidem is a prescription sedative-hypnotic medicine used for the short-term treatment of insomnia. It is an imidazopyridine and a non-benzodiazepine hypnotic. The 10 mg strength is one of the marketed tablet strengths and is used for product identification only.
Active Ingredient and Medicine Class
The active ingredient is zolpidem tartrate. Zolpidem belongs to the class of non-benzodiazepine hypnotics and acts as a GABA-A receptor positive modulator. It is chemically related to the imidazopyridines rather than to benzodiazepines.
Established Medical Uses
Zolpidem is established for the short-term management of insomnia, particularly when difficulty falling asleep is the main problem. Regulatory prescribing information also describes use for sleep maintenance with some formulations. Clinical reviews and prescribing information support its role as a hypnotic for insomnia symptoms, not as a general sleep aid for routine use.
How It Works
Zolpidem enhances the activity of gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in the brain. By strengthening GABA-mediated inhibition, it produces a sedative effect that can reduce sleep latency and help promote sleep.
Important Safety Information
Zolpidem carries an important warning for complex sleep behaviors, including activities such as sleepwalking or other actions performed while not fully awake. It should not be used in patients with a known hypersensitivity to zolpidem. Prescribing information also warns about additive effects with other central nervous system depressants, including alcohol and sedative medicines, which can increase drowsiness and impairment. Caution is also advised in patients with respiratory impairment, liver disease, a history of substance misuse, or conditions that increase the risk of confusion, falls, or next-day impairment.
Possible Side Effects
Common adverse effects include drowsiness, dizziness, headache, and next-day sedation or reduced alertness. Other recognised effects include confusion, abnormal dreams, nausea, and impaired coordination. Serious reactions can include complex sleep behaviors, allergic reactions, and excessive CNS depression, especially when combined with other sedating substances.
Scientific Evidence
Peer-reviewed reviews and clinical studies consistently show that zolpidem reduces sleep latency and can improve sleep in adults with insomnia. Published reviews also note clinically important safety concerns, including dependence potential, withdrawal symptoms in some patients, and complex sleep behaviors. Overall, the evidence supports short-term hypnotic benefit with a need for careful safety monitoring.
Medical Information Notice
This educational summary is based on sources available at the time of review and does not replace the official patient leaflet, prescribing information, or individual assessment by a qualified healthcare professional.
Medical Sources
- DailyMed — Zolpidem tartrate tablets, USP, prescribing information: View source
- Greenblatt DJ et al. — “Zolpidem for insomnia” — Expert Opinion on Pharmacotherapy, 2012: PubMed
